Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mass Clear all

Conditions: Bone Density, Cancer
Interventions: Not listed
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Osteoporosis
Interventions: Pamidronate; Drug
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 5 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Ends 2005
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Type 2 Diabetes
Interventions: Sitagliptin; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Osteoporosis, Osteopenia, Vitamin D Deficiency, Hypoparathyroidism, Hypercalciuria, Hypercalcemia
Interventions: Vitamin D; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 50 Years to 66 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Exercise, Healthy
Interventions: Osteogenic Index Optimized Exercise Training Program; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 40 Years
Enrollment: 206 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Lawrence, Kansas • Pittsburgh, Pennsylvania

Conditions: Distal Radius Fractures, Poor Bone Quality, Treatment Complications
Interventions: Not listed
Lead sponsor: AO Clinical Investigation and Publishing Documentation; Other
Eligibility: 50 Years to 90 Years
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Low Bone Density, Osteopenia, Osteoporosis, Postmenopausal
Interventions: Strontium L-lactate; Dietary Supplement
Lead sponsor: BioLink Life Sciences, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Addison, Illinois

Conditions: Osteoporosis
Interventions: Teriparatide, Alendronate Sodium, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 21 Years and older
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 6
States / cities: Loma Linda, California • Palo Alto, California • Aurora, Colorado + 3 more

Conditions: Bone Density, Energy Availability
Interventions: Not listed
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 15 Years to 17 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Davis, California

Conditions: Prostate Cancer
Interventions: zoledronic acid; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 44
States / cities: Birmingham, Alabama • Huntsville, Alabama • Anchorage, Alaska + 38 more

Conditions: HIV Infections, Menopause
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years to 52 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anorexia Nervosa
Interventions: Transdermal estrogen, Placebos; Drug
Lead sponsor: Pouneh K. Fazeli, MD; Other
Eligibility: 19 Years to 45 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Bone Density
Interventions: high frequency voluntary apheresis blood donation; Procedure
Lead sponsor: Versiti Blood Health; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Phenylketonuria
Interventions: KuvanTM Therapy; Drug
Lead sponsor: Emory University; Other
Eligibility: 4 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Postmenopausal Osteoporosis
Interventions: Dried Plum, Calcium supplement, Vitamin D supplement; Dietary Supplement
Lead sponsor: Penn State University; Other
Eligibility: 55 Years to 75 Years · Female only
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Osteoporosis, Fracture, Aging
Interventions: Not listed
Lead sponsor: Artann Laboratories; Industry
Eligibility: Female only
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Spinal Cord Injury, Bone Loss, Osteoporosis
Interventions: Alendronate, Calcium, Vitamin D; Drug · Dietary Supplement
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hereditary Breast and Ovarian Cancer Syndrome, Osteoporosis, Ovarian Carcinoma
Interventions: Laboratory Biomarker Analysis, Zoledronic Acid; Other · Drug
Lead sponsor: Gynecologic Oncology Group; Network
Eligibility: Female only
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 95
States / cities: Scottsdale, Arizona • Tucson, Arizona • Burbank, California + 76 more

Conditions: Rheumatoid Arthritis
Interventions: Not listed
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 1,745 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Breast Neoplasms
Interventions: Zometa, Epirubicin, Docetaxel, Trastuzumab, External beam radiation, Modified radical mastectomy or breast conserving surgery with axillary lymph node dissection; Drug · Radiation · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2011
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Osteoporosis
Interventions: Alendronate; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 5 Years to 15 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Osteopenia, Osteoporosis
Interventions: Alendronate, Estrogen/progestin therapy; Drug
Lead sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); NIH
Eligibility: 60 Years and older · Female only
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2004
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Osteoporosis, Obesity, Weight Loss
Interventions: Exercise and weight loss intervention; Other
Lead sponsor: University of North Carolina, Greensboro; Other
Eligibility: 23 Years to 40 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: Osteoporosis, Hip Fracture
Interventions: Zoledronic Acid; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 50 Years and older
Enrollment: 2,127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 27
States / cities: Birmingham, Alabama • Eureka, California • La Mesa, California + 24 more

Search by objective public record fields.

Screening of Bone Mineral Density in Women Who Have Received Chemotherapy

Prevention of Steroid-Induced Osteoporosis in Children

Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus

Does Treatment of Hypovitaminosis D Increase Calcium Absorption?

Bone and Body Composition Adaptations to Physical Training

The Influence of Local Bone Status on Complications After Surgical Treatment of Distal Radius Fractures

Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults

Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis

Low Energy Availability, Menstrual Irregularity, and Low Bone Mass

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

Metabolic and Psychological Changes Associated With Menopause Among Women With HIV

Transdermal Estrogen in Women With Anorexia Nervosa

Bone Density in Voluntary Apheresis Blood Donors

Nutritional and Neurotransmitter Changes in PKU Subjects on BH4

Dried Plums and Bone Health in Postmenopausal Women

Develop and Validate Ultrasonic Device for Osteoporotic Fracture Risk Assessment

Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis

Breastfeeding and Exercise for Healthy Infants and Postpartum Moms Too!

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture